Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | HBB | P68871 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL261620 | 0.81 | TP53 (0.42) | TP53HBBSMN1; SMN2OPRM1OPRK1 | |
| SCHEMBL11152227 | 0.80 | TP53 (0.41) | TP53HBBSMN1; SMN2OPRM1OPRK1 | |
| SCHEMBL25137100 | 0.80 | TP53 (0.41) | TP53HBBSMN1; SMN2OPRM1OPRK1 | |
| SCHEMBL11089324 | 0.79 | TP53 (0.47) | TP53HBBSMN1; SMN2OPRM1OPRK1 | |
| SCHEMBL12268497 | 0.75 | TP53 (0.47) | TP53HBBSMN1; SMN2OPRM1OPRK1 | |
| SCHEMBL8912098 | 0.74 | POLB (0.45) | — | |
| SCHEMBL11756952 | 0.73 | TP53 (0.41) | TP53HBBSMN1; SMN2DHFR | |
| SCHEMBL21119006 | 0.73 | TP53 (0.64) | TP53HBBSMN1; SMN2OPRM1OPRK1 | |
| SCHEMBL21119007 | 0.73 | TP53 (0.64) | TP53HBBSMN1; SMN2OPRM1OPRK1 | |
| SCHEMBL11679953 | 0.73 | TP53 (0.35) | TP53HBBSMN1; SMN2OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8821907-B2 | Biocidal N-halamine epoxides | AUBURN UNIVERSITY OFFICE OF TECHNOLOGY TRANSFER (US) | 2014-09-02 | — | — | US | disclosed |
| US-20070015921-A1 | Biocidal N-Halamine epoxides | AUBURN UNIVERSITY | 2007-01-18 | — | — | US | disclosed |
| WO-2006099567-A2 | BIOCIDAL N-HALAMINE EPOXIDES | AUBURN UNIVERSITY (US) | 2006-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015921-A1 | Biocidal N-Halamine epoxides | HNMT, HCK, CHIA | TP53 2070/4885HBB 898/4885SMN1; SMN2 4587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.